Time for a strategic research response to anal cancer

被引：10
|
作者：
Grulich, Andrew E. [1 ]
Hillman, Richard [1 ,2 ]
Brotherton, Julia M. L. [3 ,4 ]
Fairley, Christopher K. [4 ,5 ]
机构：
[1] Univ New S Wales, Kirby Inst, Sydney, NSW 2052, Australia
[2] Univ Sydney, Ctr Infect Dis & Microbiol Sexual Hlth, Sydney, NSW 2006, Australia
[3] Victorian Cytol Serv, Melbourne, Vic 3002, Australia
[4] Univ Melbourne, Sch Populat Hlth, Melbourne, Vic 3010, Australia
[5] Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic 3010, Australia
来源：
SEXUAL HEALTH | 2012年 / 9卷 / 06期
关键词：
human papillomavirus; incidence; prevalence; prevention; screening; treatment; HUMAN-PAPILLOMAVIRUS INFECTION; CERVICAL INTRAEPITHELIAL NEOPLASIA; PROSTATE-CANCER; NATURAL-HISTORY; HPV INFECTION; RISK-FACTORS; WOMEN; SEX; MEN; EPIDEMIOLOGY;
D O I：
10.1071/SH12116
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
Anal cancer was until recently regarded as a rare cancer of little consequence. The articles in this special edition of Sexual Health clearly demonstrate that anal cancer is increasing in incidence and, in some populations, it has become an urgent public health priority. In this summary paper, we will review the data presented in this issue and elsewhere on the magnitude of the issue, the means of prevention and treatment, and suggest a way forward.
引用
收藏
页码：628 / 631
页数：4
相关论文
共 50 条
  • [41] Tomotherapy for anal cancer: analysis of toxicity and response in a dual institution experience
    Bonomo, P.
    Meduri, B.
    D'Angelo, E.
    Galardi, A.
    Paoli, C. Delli
    Tata, C.
    De Marco, G.
    Desideri, I.
    Bertoni, F.
    Livi, L.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S609 - S610
  • [42] Is It Time for Risk-based Screening Guidelines for the Prevention of Anal Cancer?
    Castle, Philip E.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (01) : 30 - 32
  • [43] Time dependency for HPV ctDNA detection as a prognostic biomarker for anal cancer
    Morris, Van K., II
    Xiao, Weihong
    Holliday, Emma B.
    Lin, Kangyu
    Huey, Ryan W.
    Noticewala, Sonal S.
    Ludmir, Ethan B.
    Bent, Alisha Heather
    Higbie, Victoria
    Koay, Eugene Jon
    Koong, Albert C.
    Das, Prajnan
    Gillison, Maura L.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [44] Disparities in the Epidemiology of Anal Cancer: A Cross-Sectional Time Series
    Oliveira, Carlos R.
    Niu, Yu S.
    Einarsdottir, Hulda M.
    Niccolai, Linda M.
    Shapiro, Eugene D.
    HEALTH EQUITY, 2020, 4 (01) : 382 - 385
  • [45] It's time to consider screening for anal cancer in high risk populations
    Wei, Matthew Y.
    Yeung, Justin M.
    Faragher, Ian G.
    ANZ JOURNAL OF SURGERY, 2024, 94 (10) : 1681 - 1682
  • [46] Design of the ANal Cancer/HSIL Outcomes Research study (ANCHOR study): A randomized study to prevent anal cancer among persons living with HIV
    Lee, Jeannette Y.
    Lensing, Shelly Y.
    Berry-Lawhorn, J. Michael
    Jay, Naomi
    Darragh, Teresa M.
    Goldstone, Stephen E.
    Wilkin, Timothy J.
    Stier, Elizabeth A.
    Einstein, Mark
    Pugliese, Julia C.
    Palefsky, Joel M.
    CONTEMPORARY CLINICAL TRIALS, 2022, 113
  • [47] NanoTRAIL-Oncology: A Strategic Approach in Cancer Research and Therapy
    Shi, Yesi
    Pang, Xin
    Wang, Junqing
    Liu, Gang
    ADVANCED HEALTHCARE MATERIALS, 2018, 7 (11)
  • [48] Strategic research
    MacLane, S
    SCIENCE, 1996, 274 (5286) : 325 - 326
  • [49] STRATEGIC RESEARCH
    MICHIE, D
    NATURE, 1972, 240 (5381) : 427 - &
  • [50] RESPONSE OF THE ANAL CANAL TO STRETCH AND ANAL ACOUSTIC REFLECTOMETRY
    Nicholson, J.
    Pearson, J.
    Sharma, A.
    Telford, K.
    Kiff, E.
    GUT, 2015, 64 : A382 - A382
12345